A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 May 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 May 2017 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017.
- 02 Dec 2014 Phase assumed.